| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 368-380, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
JH Levine, HL Moses, LI Gold and LB Nanney
Department of Surgery, Vanderbilt University, School of Medicine, Nashville, Tennessee 37232.
Transforming growth factor beta (TGF-beta) regulates cellular growth and differentiation and stimulates the synthesis and secretion of protein constituents of the extracellular matrix. Three isoforms of TGF- beta have been found in mammals. Although the biological activities of TGF-beta 1, TGF-beta 2, and TGF-beta 3 are similar at the level of cell culture, distinct in vivo functions for these molecules are emerging. To gain insight into the role of each isoform in wound repair, antibodies specific for each isoform of TGF-beta were used to examine excisional wound repair. Marked differences in the temporal and spatial relationships for immunoreactive TGF-beta 1, -beta 2, and -beta 3 were noted throughout the repair process. TGF-beta 2 and TGF-beta 3 were prevalent by 24 hours after excisional wounding, and strong immunoreactivity was observed in the migrating epidermis. Subtle changes in immunoreactivity occurred for TGF-beta 2 and TGF-beta 3 in cells of the epidermal appendages, mesenchymal derivatives, granulation tissue, and the underlying dermis throughout wound repair. In contrast, TGF-beta 1 was not associated with any undifferentiated cells and was not present in the dermis and most dermal structures in both nonwounded skin or wounds until day 5 after wounding, when re-epithelialization was complete. Following re-epithelialization, TGF-beta 2 and TGF-beta 3 were present in all four layers of stratum corneum of the differentiating epidermis. All three TGF-beta isoforms were present in mesenchymal cells and basal lamina, suggesting their role in the modulation of dermal-epidermal interaction during wound repair. Our observations support individual in vivo function for TGF-beta isoforms in cutaneous wound repair.
This article has been cited by other articles:
 |
|
 |
|
  P. Durani, N. Occleston, S. O'Kane, and M. W. J. Ferguson Avotermin: A Novel Antiscarring Agent International Journal of Lower Extremity Wounds, September 1, 2008; 7(3): 160 - 168. [Abstract] [PDF]
|
|
|
|
 |
|
 L. B. Nanney, C. D. Woodrell, M. R. Greives, N. L. Cardwell, A. C. Pollins, T. A. Bancroft, A. Chesser, M. Michalak, M. Rahman, J. W. Siebert, et al. Calreticulin Enhances Porcine Wound Repair by Diverse Biological Effects Am. J. Pathol., September 1, 2008; 173(3): 610 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Verona, Y. Tang, T. K. Millstead, A. P. Hinck, J. K. Agyin, and L.-Z. Sun Expression, purification and characterization of BGERII: a novel pan-TGF{beta} inhibitor Protein Eng. Des. Sel., July 1, 2008; 21(7): 463 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chen, C. R. Jackson, A. Link, M. P. Markey, B. M. Colligan, L. E. Douglass, J. O. Pemberton, J. A. Deddens, J. R. Graff, and J. H. Carter Int7G24A Variant of Transforming Growth Factor-{beta} Receptor Type I Is Associated with Invasive Breast Cancer Clin. Cancer Res., January 15, 2006; 12(2): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-E. Oh, J.-K. Kook, and B.-M. Min {beta}ig-h3 Induces Keratinocyte Differentiation via Modulation of Involucrin and Transglutaminase Expression through the Integrin {alpha}3{beta}1 and the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway J. Biol. Chem., June 3, 2005; 280(22): 21629 - 21637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grisanti, P. Szurman, M. Warga, R. Kaczmarek, F. Ziemssen, O. Tatar, and K. U. Bartz-Schmidt Decorin Modulates Wound Healing in Experimental Glaucoma Filtration Surgery: A Pilot Study Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Esson, A. Neelakantan, S. A. Iyer, T. D. Blalock, L. Balasubramanian, G. R. Grotendorst, G. S. Schultz, and M. B. Sherwood Expression of Connective Tissue Growth Factor after Glaucoma Filtration Surgery in a Rabbit Model Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Soo, S. R. Beanes, F.-Y. Hu, X. Zhang, C. Dang, G. Chang, Y. Wang, I. Nishimura, E. Freymiller, M. T. Longaker, et al. Ontogenetic Transition in Fetal Wound Transforming Growth Factor-{beta} Regulation Correlates with Collagen Organization Am. J. Pathol., December 1, 2003; 163(6): 2459 - 2476. [Abstract] [Full Text]
|
|
|
|
|
|
J. T. Daniels, G. S. Schultz, T. D. Blalock, Q. Garrett, G. R. Grotendorst, N. M. Dean, and P. T. Khaw Mediation of Transforming Growth Factor-{beta}1-Stimulated Matrix Contraction by Fibroblasts: A Role for Connective Tissue Growth Factor in Contractile Scarring Am. J. Pathol., November 1, 2003; 163(5): 2043 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Stramer, J. D. Zieske, J.-C. Jung, J. S. Austin, and M. E. Fini Molecular Mechanisms Controlling the Fibrotic Repair Phenotype in Cornea: Implications for Surgical Outcomes Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4237 - 4246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. WERNER and R. GROSE Regulation of Wound Healing by Growth Factors and Cytokines Physiol Rev, July 1, 2003; 83(3): 835 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Agah, T. R. Kyriakides, J. Lawler, and P. Bornstein The Lack of Thrombospondin-1 (TSP1) Dictates the Course of Wound Healing in Double-TSP1/TSP2-Null Mice Am. J. Pathol., September 1, 2002; 161(3): 831 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saika, T. Miyamoto, T. Tanaka, I. Ishida, Y. Ohnishi, and A. Ooshima Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells Br. J. Ophthalmol., November 1, 2001; 85(11): 1362 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Laitakari and F. Stenback Collagen Matrix in Development and Progression of Experimentally Induced Respiratory Neoplasms in the Hamster Toxicol Pathol, August 1, 2001; 29(5): 514 - 527. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. ITO, R. GOLDSCHMEDING, R. J. BENDE, N. CLAESSEN, M. A. CHAND, L. KLEIJ, T. J. RABELINK, J. J. WEENING, and J. ATEN Kinetics of Connective Tissue Growth Factor Expression during Experimental Proliferative Glomerulonephritis J. Am. Soc. Nephrol., March 1, 2001; 12(3): 472 - 484. [Abstract] [Full Text]
|
|
|
|
|
|
C. Soo, F.-Y. Hu, X. Zhang, Y. Wang, S. R. Beanes, H. P. Lorenz, M. H. Hedrick, R. J. Mackool, A. Plaas, S.-J. Kim, et al. Differential Expression of Fibromodulin, a Transforming Growth Factor-{beta} Modulator, in Fetal Skin Development and Scarless Repair Am. J. Pathol., August 1, 2000; 157(2): 423 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, S. S. Bhattacharya, G. S. Schultz, and P. T. Khaw TGF-{beta}1, -{beta}2, and -{beta}3 In Vitro: Biphasic Effects on Tenon’s Fibroblast Contraction, Proliferation, and Migration Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 756 - 763. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Cordeiro, J. A. Gay, and P. T. Khaw Human Anti-Transforming Growth Factor-{beta}2 Antibody: A New Glaucoma Anti-Scarring Agent Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2225 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, M. B. Reichel, J. A. Gay, F. D’Esposita, R. A. Alexander, and P. T. Khaw Transforming Growth Factor-{beta}1, -{beta}2, and -{beta}3 In Vivo: Effects on Normal and Mitomycin C-Modulated Conjunctival Scarring Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1975 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pellaud, U. Schote, T. Arvinte, and J. Seelig Conformation and Self-association of Human Recombinant Transforming Growth Factor-beta 3 in Aqueous Solutions J. Biol. Chem., March 19, 1999; 274(12): 7699 - 7704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M F CORDEIRO and P T KHAW The healing optic nerve in glaucoma: transforming growth factor beta and optic nerve head remodelling Br. J. Ophthalmol., February 1, 1999; 83(2): 132 - 133. [Full Text]
|
|
|
|
|
|
H. Mietz, P. Chévez-Barrios, R. M Feldman, and M. W Lieberman Suramin inhibits wound healing following filtering procedures for glaucoma Br. J. Ophthalmol., July 1, 1998; 82(7): 816 - 820. [Abstract] [Full Text]
|
|
|
|
|
|
M. Demetriou, C. Binkert, B. Sukhu, H. C. Tenenbaum, and J. W. Dennis Fetuin/alpha 2-HS Glycoprotein Is a Transforming Growth Factor-beta Type II Receptor Mimic and Cytokine Antagonist J. Biol. Chem., May 31, 1996; 271(22): 12755 - 12761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Frank, M. Madlener, and S. Werner Transforming Growth Factors beta1, beta2, and beta3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound Healing J. Biol. Chem., April 26, 1996; 271(17): 10188 - 10193. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
